Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem
Researcher: Dr. Miriam I. Rosenberg
Current Role & Affiliation
Title/Position: Visiting Scientist
Institution: Hebrew University of Jerusalem, Givat Ram, Department of Genetics
Email: me166@nyu.edu
Phone: 058-6474267
Dr. Rosenberg conducts research on micropeptides and their potential roles as biomarkers and players in disease pathology.
Research Focus
● Micropeptides as disease biomarkers
● Gene regulatory networks
● Neurodevelopment and neuropathologies
● Cancer biology and tumor immunology
Current Projects Related to Pediatric Brain Tumors
● Functional annotation of micropeptides
● Investigation of micropeptides in neuroblastoma and paraneoplastic neuroimmune diseases
Laboratory/Research Resources
● Molecular biology and genomic analysis tools
● Functional genomics platforms
Collaboration Interests
● Micropeptide research
● Neuroimmune disease studies
What You Can Offer Potential Collaborators
● Expertise in transcriptional control and gene regulatory networks
● Open-access data sharing and collaborative research insights
Selected Publications
1. Rosenberg MI, et.al. Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.Cell Rep. 2023 Aug 29;42(8):112879. doi: 10.1016/j.celrep.2023.112879. Epub 2023 Aug 2.PMID: 37537844 Free PMC article.
2. Chattopadhyay S, et.al. RNA-controlled nucleocytoplasmic shuttling of mRNA decay factors regulates mRNA synthesis and a novel mRNA decay pathway.Nat Commun. 2022 Nov 23;13(1):7184.
Keywords
Micropeptides, Gene Regulation, Neuroblastoma, Neuroimmune Diseases, Cancer Biology
Brief Bio
Dr. Miriam I. Rosenberg is a distinguished scientist specializing in developmental biology and gene regulation. Her current research at the Hebrew University focuses on micropeptides as potential biomarkers and contributors to disease pathology, particularly in neuroblastoma. Driven by personal experience as the parent of an affected child, Dr. Rosenberg brings unique insights into both research and clinical aspects of neuroimmune diseases.
